OK Biotech Co., Ltd. (TPE:4155)
15.50
-0.70 (-4.32%)
Nov 20, 2026, 1:30 PM CST
OK Biotech Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,723 | 1,556 | 1,670 | 1,192 | 1,484 | 1,263 |
Revenue Growth | 5.09% | -6.81% | 40.11% | -19.65% | 17.42% | -14.89% |
Gross Profit Gross Profit Growth | 546.74 | 429.25 | 275.66 | 196.88 | 344.96 | 186.83 |
Operating Income Operating Income Growth | 293.08 | 107.89 | 57.21 | -12.06 | 101.81 | 8.09 |
Net Income Net Income Growth | 251.03 | 82.45 | 93.98 | 2.95 | 143.46 | 43.46 |
Earnings Per Share EPS Growth | 1.97 | 0.64 | 0.72 | 0.02 | 1.30 | 0.46 |
EPS Growth | 274.82% | -11.55% | 3121.00% | -98.28% | 182.57% | -68.83% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Patient Monitoring Equipment Patient Monitoring Equipment Growth | 1,804 | 1,886 | 1,208 | 1,493 | 1,267 |
Intersegment Intersegment Growth | -247.93 | -215.55 | -16.37 | -9.78 | -3.4 |
Total Total Growth | 1,556 | 1,670 | 1,192 | 1,484 | 1,263 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 424.35 | 327.06 | 290.5 | 365.34 | 636.64 | 644.64 |
Total Debt Total Debt Growth | 1,068 | 1,013 | 720.05 | 331.95 | 780.63 | 733.86 |
Net Cash (Debt) Net Cash Growth | -643.87 | -686.09 | -429.55 | 33.39 | -143.98 | -89.22 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -5.05 | -5.25 | -3.27 | 0.29 | -1.23 | -0.84 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 492.52 | 318.86 | 65.9 | 2.93 | 240.53 | 21.9 |
Capital Expenditures CapEx Growth | -228.96 | -409.14 | -376.69 | -429.68 | -286.84 | -79.06 |
Free Cash Flow Free Cash Flow Growth | 263.56 | -90.28 | -310.79 | -426.74 | -46.31 | -57.16 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 31.73% | 27.58% | 16.51% | 16.52% | 23.25% | 14.79% |
Operating Margin | 17.01% | 6.93% | 3.43% | -1.01% | 6.86% | 0.64% |
Pretax Margin | 19.05% | 6.67% | 7.61% | 0.67% | 11.84% | 3.65% |
Profit Margin | 14.57% | 5.30% | 5.63% | 0.25% | 9.67% | 3.44% |
FCF Margin | 15.30% | -5.80% | -18.61% | -35.80% | -3.12% | -4.52% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.335 | 0.335 | 0.335 | 0.335 | 1.244 | 1.012 |
Dividend Per Share Growth | 0% | 0% | 0% | -73.11% | 22.94% | -28.57% |
Dividend Yield | 2.16% | 2.07% | 1.43% | 1.20% | 4.63% | 4.28% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 7.85 | 24.87 | 32.00 | 1240.26 | 18.42 | 51.00 |
Forward PE | - | 16.30 | 16.30 | 16.30 | 16.30 | 16.30 |
PS Ratio | 1.11 | 1.32 | 1.80 | 3.07 | 1.78 | 1.76 |